Akeso, Inc. (HKG: 9926)
Hong Kong
· Delayed Price · Currency is HKD
57.40
-1.95 (-3.29%)
Jan 7, 2025, 4:08 PM HKT
Akeso Employees
Akeso had 2,778 employees as of December 31, 2023. The number of employees increased by 437 or 18.67% compared to the previous year.
Employees
2,778
Change (1Y)
437
Growth (1Y)
18.67%
Revenue / Employee
715.37K HKD
Profits / Employee
-280.68K HKD
Market Cap
50.44B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2,778 | 437 | 18.67% |
Dec 31, 2022 | 2,341 | 476 | 25.52% |
Dec 31, 2021 | 1,865 | 1,119 | 150.00% |
Dec 31, 2020 | 746 | 356 | 91.28% |
Dec 31, 2019 | 390 | - | - |
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 10,600 |
Hansoh Pharmaceutical Group Company | 9,123 |
JD Health International | 3,118 |
WuXi Biologics | 12,740 |
Sinopharm Group | 115,959 |
Innovent Biologics | 4,872 |
Sino Biopharmaceutical | 25,806 |
Alibaba Health Information Technology | 1,435 |
Akeso News
- 2 months ago - BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential - Benzinga
- 2 months ago - Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo - Benzinga